Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
Upturn AI SWOT - About
iShares Trust - iShares Neuroscience and Healthcare ETF (IBRN)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/24/2025: IBRN (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type ETF | Historic Profit 31.72% | Avg. Invested days 59 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  3.0 | ETF Returns Performance  5.0 |
| Profits based on simulation | Last Close 10/24/2025 |
Key Highlights
Volume (30-day avg) - | Beta - | 52 Weeks Range 17.86 - 28.63 | Updated Date 06/29/2025 |
52 Weeks Range 17.86 - 28.63 | Updated Date 06/29/2025 |
Upturn AI SWOT
iShares Trust - iShares Neuroscience and Healthcare ETF
ETF Overview
Overview
The iShares Neuroscience and Healthcare ETF (IBRN) seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from advancements in neuroscience, and companies that offer products, services, and equipment used in the healthcare sector.
Reputation and Reliability
iShares is a well-established and reputable ETF provider with a long track record of managing various investment products.
Management Expertise
BlackRock, the issuer of iShares ETFs, possesses extensive experience and expertise in investment management, particularly in the ETF space.
Investment Objective
Goal
To track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from advancements in neuroscience, and companies that offer products, services, and equipment used in the healthcare sector.
Investment Approach and Strategy
Strategy: The ETF aims to track a specific index related to neuroscience and healthcare companies.
Composition The ETF primarily holds stocks of companies involved in neuroscience and healthcare.
Market Position
Market Share: Data unavailable to determine IBRN market share.
Total Net Assets (AUM): Data unavailable, unable to calculate. Please see source links.
Competitors
Key Competitors
Competitive Landscape
The competitive landscape for this ETF depends on the specific index it tracks. Without market share data for this ETF or its competitors, a meaningful comparison is difficult. The advantage of IBRN lies in its specific focus on neuroscience and healthcare.
Financial Performance
Historical Performance: Historical performance data is needed from sources to populate this response. Please see source links.
Benchmark Comparison: A benchmark comparison requires historical performance data of the ETF and its benchmark index. Please see source links.
Expense Ratio: 0.47%
Liquidity
Average Trading Volume
Average trading volume is unavailable without live data, but can be found in source links.
Bid-Ask Spread
Bid-ask spread data is real-time and can only be acquired via a live data feed. Please see source links.
Market Dynamics
Market Environment Factors
Economic indicators affecting the healthcare and biotechnology sectors, advancements in neuroscience, and regulatory changes can all impact IBRN.
Growth Trajectory
The growth trajectory of IBRN depends on the performance of the neuroscience and healthcare sectors, as well as any changes in the ETF's underlying index or holdings.
Moat and Competitive Advantages
Competitive Edge
IBRN's competitive edge comes from its focused exposure to the neuroscience and healthcare sectors, offering investors a targeted way to participate in the growth potential of these industries. The fund is managed by BlackRock, a well-regarded asset manager, providing credibility and experience. This targeted approach may be advantageous for investors seeking specialized exposure within the broader healthcare market. However, its success will depend on the performance of the specific companies held within the fund.
Risk Analysis
Volatility
The volatility of IBRN will depend on the volatility of the underlying stocks in the neuroscience and healthcare sectors.
Market Risk
Specific risks include regulatory hurdles for pharmaceutical companies, competition within the industry, and the success or failure of clinical trials for neuroscience-related treatments.
Investor Profile
Ideal Investor Profile
The ideal investor for IBRN is someone who is bullish on the long-term growth prospects of the neuroscience and healthcare industries.
Market Risk
IBRN is suitable for long-term investors seeking targeted exposure to the neuroscience and healthcare sectors, and who are comfortable with the associated risks.
Summary
The iShares Neuroscience and Healthcare ETF (IBRN) offers targeted exposure to companies involved in neuroscience advancements and healthcare services. Managed by BlackRock, IBRN seeks to track a specific index related to these sectors. Its competitive edge lies in its focused approach, allowing investors to participate in the potential growth of these industries. Investors should consider the risks associated with sector-specific investments and the potential for volatility within the healthcare and biotechnology markets. Please refer to the source links for live market information and performance history.
Peer Comparison
Sources and Disclaimers
Data Sources:
- iShares website
- ETF.com
- SEC filings
Disclaimers:
The data provided is for informational purposes only and does not constitute investment advice. Investors should conduct their own research and consult with a financial advisor before making any investment decisions. Market data is subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About iShares Trust - iShares Neuroscience and Healthcare ETF
Exchange NYSE ARCA | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website | ||
The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index. It is non-diversified.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.